Q4 2023 Abbvie Inc Earnings Call - Yahoo Finance

Summary

The article text provides a comprehensive transcript from AbbVie's fourth-quarter 2023 earnings conference call, including discussions on financial results, executive commentary, updates on key products such as Skyrizi and Rinvoq, and insights into R&D pipelines and strategies. The key concept 'biopharma' relates to AbbVie Inc., a biopharmaceutical company, while the tags list various entities and individuals connected to the pharmaceutical industry and AbbVie's business, such as Adalimumab (known as Humira), Allergan, and financial institutions like Citigroup Inc. and Barclays Bank PLC that provide analysis and research coverage for the company. The article details are pertinent to the pharmaceutical industry's financial health, product performance, and future outlook, particularly in the United States.